24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
HEOR and RWE in the COVID-19 pandemic: highlights from the first virtual ISPOR meeting In May 2020, members of the Oxford PharmaGenesis Value Demonstration Practice joined more than 1300 health economic and outcomes research (HEOR) and market access professionals from 54 countries for the first ever fully virtual ISPOR meeting, participating in a broad range…
In February 2020, a small group of medical publication professionals from pharmaceutical, publishing and medical communications companies came together in San Diego, CA for TIPPA 2020. Oxford PharmaGenesis attended as a gold sponsor of the event, with Brian Falcone, Ruvini Jayasinghe and Rachel Brown from the Philadelphia office on hand for two full days of…
Oxford PharmaGenesis celebrated the official opening of its newest regional office on 27 February by holding a launch event at Melbourne’s Bio21 Institute. The attendee list included representatives from: current and potential client companies; universities and hospitals; the Victorian state government; partner organizations; and patient groups.
To mark Rare Disease Day 2020, Oxford PharmaGenesis held a series of talks in the Oxford office that focused on the patients’ perspective of living with a rare disease. Colleagues from the Oxford Central, London, Cardiff, Cambridge and Philadelphia offices dialled in to take part.
In January 2020 over 350 medical publication professionals from across industry, publishers and agencies came together in London to attend the European meeting of ISMPP; we were there as a 10-strong team to experience first hand the engaging programme on offer. We were also lucky enough to have six posters accepted, including two oral poster…
During a busy week for Oxford PharmaGenesis, a successful Open Pharma roundtable and ISMPP EU conference were followed by a plenary presentation at the opening session of CBI’s 7th Annual Clinical Data Disclosure, Transparency & Plain Language Summaries Conference in Miami, FL, USA (22–24 January 2020).
